BlueCrest Capital Management’s Chemours CC Stock Holding History

BlueCrest Capital Management’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-7,300	Closed	-$271K	–	502
2019 Q1	$271K	Sell	7,300 -612	-8%	-$22.3K	0.01%	762
2018 Q4	$223K	Buy	+7,912	New	+$250K	0.01%	612
2018 Q3	–	Sell	-15,702	Closed	-$697K	–	1531
2018 Q2	$697K	Sell	15,702 -67,475	-81%	-$3.36M	0.02%	672
2018 Q1	$4.05M	Buy	+83,177	New	+$4.16M	0.13%	169
2017 Q4	–	Sell	-76,403	Closed	-$3.87M	–	859
2017 Q3	$3.87M	Sell	76,403 -316,609	-81%	-$14.9M	0.16%	161
2017 Q2	$14.9M	Buy	+393,012	New	+$15.5M	0.58%	24
2016 Q2	–	Sell	-115,812	Closed	-$811K	–	868
2016 Q1	$811K	Buy	+115,812	New	+$582K	0.05%	418

Other funds holding CC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlueCrest Capital Management's CC Position: Q2 2019 in Review

BlueCrest Capital Management sold out of Chemours (CC) in Q2 2019, closing a stake of 7,300 shares — an estimated $271K sold.

BlueCrest Capital Management first reported a position in CC in Q1 2016 and held it in 7 quarters. The position peaked at $14.9M in Q2 2017. 488 funds tracked by Wall St. Rank hold CC as of Q2 2019.

BlueCrest Capital Management reported no remaining Chemours position as of Q2 2019 after selling out during the quarter.
BlueCrest Capital Management sold 7,300 Chemours shares in Q2 2019, an estimated $271K.
BlueCrest Capital Management first reported a position in Chemours in Q1 2016 and held it in 7 quarters.
BlueCrest Capital Management's Chemours position peaked at $14.9M in Q2 2017.
488 funds tracked by Wall St. Rank held Chemours as of Q2 2019.

Based on BlueCrest Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.